Formulation Characterization Optimization of Duloxetine loaded Ethosome Patch for Transdermal Application
-
Published:2022-12-24
Issue:
Volume:
Page:5565-5570
-
ISSN:0974-360X
-
Container-title:Research Journal of Pharmacy and Technology
-
language:en
-
Short-container-title:RJPT
Author:
Kumar A. Eswar1, Patra Ch. Niranjan2
Affiliation:
1. Department of Pharmaceutics, University College of Pharmaceutical Sciences, Palamuru University, Mahabubnagar, 509001, Telangana, India. 2. Professor, Department of Pharmaceutics, Roland Institute of Pharmaceutical Sciences, Orissa, India.
Abstract
The present investigation deals with the development of duloxetine ethosome then loading into transdermal patch to impart lower drug side effect, enhanced bioavailability, avoid first pass metabolismt.32 factorial design was applied to optimize the formulation. Materials and Methods, Ethanol (X1) and Phospholipid (X2) were taken as independent variable, Responses are vesicle size (Y2), entrapment efficiency (Y1). Optimum desirability was identified and, an optimized formulation was prepared, characterized and loaded into transdermal films. Ex-vivo permeation study for the prepared films was conducted and, the permeation parameters and drug permeation mechanism were identified. Results The percent of alcohol was significantly affecting all the studied responses while the other factors and their interaction effects were varied on their effects on each response. The optimized ethosomes formulation showed observed values for Y2, Y1 a of 161nm and 98.79% respectively. Ex-vivo permeation of films loaded with optimized ethosomal formulation was superior to that of the corresponding pure drug transdermal films.
Publisher
A and V Publications
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference20 articles.
1. Tarek A. Ahmed, Khalid M. El-Saya,b, Bader M. Aljaeida, Usama A. Fahmya, Fathy I. Abd-Allah Transdermal duloxetine delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro,ex vivo and clinical evaluation, Pharmaceutical Nanotechnology. International Journal of Pharmaceutics. 2016, (500) 245-254 2. Ah, Y.-C., Choi, J.-K., Choi, Y.-K., Ki, H.-M., Bae, J.-H.et al . A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int. J. Pharm. 385 (1-2), 12–19 https://doi.org/10.1016/j.ijpharm.2009.10.013 3. Dubey, V., Mishra, D., Dutta, T., Nahar, M., Saraf, D.K., Jain, N.K, Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control. Release. 2007https://doi.org/10.1016/j.jconrel.2007.08.005 4. Abdel Messih, H.A., Ishak, R.A., Geneidi, A.S., Mansour, S., 2017. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation. Drug Dev. Ind. Pharm. 43, 958–971. https://doi.org/10.1080/03639045.2017.1287717 5. Touitou, E., Godin, B., Dayan, N., Weiss, C., Piliponsky, A., Levi-Schaffer, F, Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001, 22 (22), 3053–3059 https://doi.org/10.1016/s0142-9612(01)00052-7
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|